In a comparison of two Medical Services stocks, Concentra Group (CON) emerges as the superior value option compared to Medpace (MEDP). CON holds a Zacks Rank of #2 (Buy) with improving earnings outlook and more attractive valuation metrics, including a forward P/E of 22.74 versus MEDP's 34.77, and a PEG ratio of 1.37 versus 2.72. CON also received a Value grade of B compared to MEDP's D grade.
CON
Concentra Group Holdings Parent, Inc. · NYSE
Sign up free to see this.
Mkt Cap
$5B
Volume
122.6K
52W High
$40.00
52W Low
$18.55
PE Ratio
25.1
Avg Vol
1.2M
As of 10/23/26
Div Yield
0.64%
Beta
0.38
As of 10/23/26
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Sentiment
No sentiment yet
At least 5 tagged posts are needed.
How do you feel about CON?
Latest news
News ›Headlines link to the publisher. Not investment advice.
Board · 0 threads
Open board ›No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Posts 24h
0
Replies 24h
0
Watchers
0
Board · $CON · 0 threads
Sign in to post on $CON
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.